TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes


One of the hallmarks of cancer is its unlimited replicative potential that needs a compensatory mechanism for the consequential telomere erosion. Telomerase promoter (TERTp) mutations were recently reported as a novel mechanism for telomerase re-activation/expression in order to maintain telomere length. Pancreatic endocrine tumors (PETs) were so far… (More)
DOI: 10.1038/srep29714


5 Figures and Tables


Citations per Year

Citation Velocity: 14

Averaging 14 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.